Advertisement

Reproductive Sciences

, Volume 19, Issue 1, pp 64–69 | Cite as

Reduced Levels of Serum Pigment Epithelium-Derived Factor in Women With Endometriosis

  • Liqing Chen
  • Ruijia Fan
  • Xiufeng Huang
  • Hong Xu
  • Xinmei ZhangEmail author
Original Articles

Abstract

The authors previously demonstrated decreased levels of pigment epithelium-derived factor (PEDF) in peritoneal fluid of women with endometriosis compared to women without endometriosis. Here, the authors determine whether women with endometriosis have altered levels of PEDF in serum. Peripheral blood samples were collected from 71 women with and without endometriosis (n = 43 and 28, respectively) before laparoscopic surgery. Concentrations of serum PEDF were measured by enzyme-linked immunosorbent assay. We detected lower levels of serum PEDF in women with endometriosis (16.3 ± 6.6 ng/mL) than in those without endometriosis (24.5 ± 7.3 ng/mL; P < .001). In women with endometriosis, the concentrations of serum PEDF were significantly lower in women with pain (n = 11, 12.6 ± 7.1 ng/mL) compared to women without pain (n = 32, 17.5 ± 6.0 ng/mL; P < .05). However, the concentrations of serum PEDF did not correlate with disease stage or site or infertility. In addition, the concentrations of serum PEDF did not show any difference in the phase of the cycle in either group. Our results suggest that reduced levels of serum PEDF in women with endometriosis and disease-related pain may play a role in the pathogenesis of this disease.

Keywords

endometriosis serum angiogenesis pigment epithelium-derived factor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zhang X, Lin J, Qian Y, Deng L. Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis. Fertil Steril. 2004;81(5):1229–1234.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod. 2009;24(3):608–618.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Cosín R, Gilabert-Estellés J, Ramón LA, et al. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis. Hum Reprod. 2010;25(2):398–405.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Fujii EY, Nakayama M, Nakagawa A. Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis. Reprod Sci. 2008;15(10):1066–1074.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Cho SH, Oh YJ, Nam A, et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am J Reprod Immunol. 2007;58(6):497–504.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Agic A, Djalali S, Wolfler MM, Halis G, Diedrich K, Hornung D. Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci. 2008;15(9):906–911.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Chae SJ, Kim H, Jee BC, Suh CS, Kim SH, Kim JG. Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis. Am J Reprod Immunol. 2008;60(5):432–439.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Ohata Y, Harada T, Miyakoda H, Taniguchi F, Iwabe T, Terakawa N. Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril. 2008;90(4):994–999.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Bourlev V, Iljasova N, Adamyan L, Larsson A, Olovsson M. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil Steril. 2010;94(1): 52–57.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Machado DE, Berardo PT, Palmero CY, Nasciutti LE. Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases. J Exp Clin Cancer Res. 2010;29:4.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Machado DE, Berardo PT, Palmero CY, Nasciutti LE. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model. Fertil Steril. 2010; 93(8):2674–2679.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Di Carlo C, Bonifacio M, Tommaselli GA, Bifulco G, Guerra G, Nappi C. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril. 2009;91(6):2315–2323.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Becker CM, D’Amato RJ. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res. 2007;74(2–3):121–130.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991;53(3):411–414.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Hoshina D, Abe R, Yamagishi SI, Shimizu H. The role of PEDF in tumor growth and metastasis. Curr Mol Med. 2010;10(3): 292–295.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Yamagishi S, Adachi H, Abe A, et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab. 2006;91(6):2447–2450.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Hiroyoshi Inoue H. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs). Diabetes Metab Res Rev. 2009;25(3): 266–271.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Zhang T, Guan M, Xu C, Chen Y, Lu Y. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci. 2007; 81(16):1256–1263.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Broadhead ML, Dass CR, Choong PF. In vitro and in vivo biological activity of PEDF against a range of tumors. Expert Opin Ther Targets. 2009;13(12):1429–1438.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Ek ET, Dass CR, Choong PF. Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol Cancer Ther. 2006;5(7): 1641–1646.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Wang JJ, Zhang SX, Mott R, et al. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am J Physiol Renal Physiol. 2008;294(5):F1166–F1173.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Zhang SX, Wang JJ, Dashti A, et al. Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein. J Mol Endocrinol. 2008;41(3):135–143.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Yang H, Cheng R, Liu G, et al. PEDF inhibits growth of retinoblastoma by anti-angiogenic activity. Cancer Sci. 2009;100(12): 2419–2425.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Yang LP, Cheng P, Peng XC, et al. Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma. J Exp Clin Cancer Res. 2009;28:75.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Lin J, Zhang X, Chen Y. Mutagen sensitivity as a susceptibility marker for endometriosis. Hum Reprod. 2003;18(10):2052–2057.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Grammatikakis I, Zervoudis S, Evangelinakis N, Tziortzioti V. Endometrium and ovarian cancer synchronous to endometriosis—a retrospective study of our experience of 7 years. J Med Life. 2010;3(1):76–79.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Chen L, Fan R, Huang X, Xu H, Zhang X. Decreased concentrations of pigment epithelium-derived factor in peritoneal fluid of patients with endometriosis. Fertil Steril. 2011;95(5): 1798–1800.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis 1996. Fertil Steril. 1997;67(5):817–821.CrossRefGoogle Scholar
  29. 29.
    Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327–346.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Becker CM, Wright RD, Satchi-Fainaro R, et al. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am J Pathol. 2006;168(6):2074–2084.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Hur SE, Lee JY, Moon HS, Chung HW. Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis. Mol Hum Reprod. 2006;12(7):421–426.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Matsuzaki S, Murakami T, Uehara S, et al. Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis. Hum Reprod. 2001;16(5):945–948.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Elayappan B, Ravinarayannan H, Pasha SP, Lee KJ, Gurunathan S. PEDF inhibits VEGF- and EPO-induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation. Angiogenesis. 2009;12(4):313–324.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Haribalaganesh R, Sheikpranbabu S, Banumathi E, Gurunathan S. Pigment epithelium-derived factor inhibits erythropoietin-induced retinal endothelial cell angiogenesis by suppression of PI3K/Akt pathway. Exp Eye Res. 2010;90(6):726–733.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Sheikpranbabu S, Ravinarayanan H, Elayappan B, Jongsun P, Gurunathan S. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells. Vascul Pharmacol. 2010;52(1–2):84–94.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Tan ML, Choong PF, Dass CR. Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion. Biochem Biophys Res Commun. 2010;398(4):613–618.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Barrier BF, Sharpe-Timms KL. Expression of soluble adhesion molecules in sera of women with stage III and IV endometriosis. J Soc Gynecol Investigl. 2002;9(2):98–101.CrossRefGoogle Scholar
  38. 38.
    Gmyrek GB, Sozanski R, Jerzak M, et al. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;122(2):199–205.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Podgaec S, Dias Junior JA, Chapron C, Oliveira RM, Baracat EC, Abrão MS. Th1 and Th2 immune responses related to pelvic endometriosis. Rev Assoc Med Bras. 2010;56(1):92–98.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Lambrinoudaki IV, Augoulea A, Christodoulakos GE, et al. Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril. 2009;91(1):46–50.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D. Oxidative stress and endometriosis. Hum Reprod. 2005;20(7): 2014–2020.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Ek ET, Dass CR, Contreras KG, Choong PF. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma. J Orthop Res. 2007;25(12):1671–1680.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Dass CR, Ek ET, Choong PF. PEDF as an emerging therapeutic candidate for osteosarcoma. Curr Cancer Drug Targets. 2008; 8(8):683–690.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Palmieri D, Watson JM, Rinehart CA. Age-related expression of PEDF/EPC-1 in human endometrial stromal fibroblasts: implications for interactive senescence. Exp Cell Res. 1999; 247(1):142–147.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Cheung LW, Au SC, Cheung AN, et al. Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology. 2006;147(9):4179–4191.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Stejskal D, Karpísek M, Svesták M, Hejduk P, Sporová L, Kotolová H. Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population. J Clin Lab Anal. 2010;24(1):17–19.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Ferrero S, Gillott DJ, Anserini P, et al. Vitamin D binding protein in endometriosis. J Soc Gynecol Investig. 2005;12(4):272–277.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Agic A, Xu H, Altgassen C, et al. Relative expression of 1, 25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007; 14(5):486–497.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Pretta S, Remorgida V, Abbamonte LH, et al. Atherosclerosis in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007;132(2):226–231.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod. 2007;22(8):2273–2278.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Verit FF, Erel O, Celik N. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod. 2008;23(1):100–104.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Kobayashi H, Yamada Y, Kanayama S, et al. The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol. 2009; 25(1):39–52.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Yamaguchi K, Mandai M, Oura T, et al. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene. 2010; 29(12):1741–1752.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Society for Reproductive Investigation 2012

Authors and Affiliations

  • Liqing Chen
    • 1
  • Ruijia Fan
    • 1
  • Xiufeng Huang
    • 1
  • Hong Xu
    • 1
  • Xinmei Zhang
    • 1
    Email author
  1. 1.Women’s Hospital, Zhejiang University School of MedicineHangzhou, ZhejiangP. R. China

Personalised recommendations